Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 9,420,000 shares, a growth of 403.7% from the October 15th total of 1,870,000 shares. Currently, 56.8% of the company’s shares are short sold. […]